Literature DB >> 2643575

Mucoid phenotype of Klebsiella pneumoniae is a plasmid-encoded virulence factor.

X Nassif1, J M Fournier, J Arondel, P J Sansonetti.   

Abstract

We have previously reported that the presence of a 180-kilobase plasmid encoding production of aerobactin was correlated with the virulence of Klebsiella pneumoniae K1 and K2 isolates. This work demonstrates that a variant of a K2 strain which has lost this plasmid, pKP100, becomes avirulent. Labeling of this plasmid with the mobilizable, replication-defective element pME28, used here as a mobilizable transposon, allowed the transfer of this plasmid into a plasmidless derivative. Virulence was restored upon reacquisition of this tagged plasmid, pKP101. In addition to aerobactin production, another phenotype could be correlated with the presence of this virulence plasmid: the mucoid phenotype of the bacterial colonies. Both wild-type and plasmidless strains are encapsulated, but only the former presented mucoid colonies. Participation of this phenotype in the virulence of K. pneumoniae was demonstrated by constructing a mutant altered in the plasmid gene encoding this phenotype. The resulting strain demonstrated a 1,000-fold decrease in virulence. Introduction of the recombinant plasmid pKP200 carrying the gene encoding this mucoid phenotype into Escherichia coli HB101 also led to the production of a mucoid phenotype. Rocket immunoelectrophoresis demonstrated that in E. coli this phenotype was due to the production of colanic acid. On the other hand, neither the overproduction of K2 capsular polysaccharide nor the presence of colanic acid was detected in mucoid strains of K. pneumoniae. We conclude that this mucoid phenotype is definitely an important virulence factor of K. pneumoniae. It is due to the plasmid-encoded production of a substance which is different from colanic acid and the capsular polysaccharide of K. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2643575      PMCID: PMC313131          DOI: 10.1128/iai.57.2.546-552.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Deg phenotype of Escherichia coli lon mutants.

Authors:  S Gottesman; D Zipser
Journal:  J Bacteriol       Date:  1978-02       Impact factor: 3.490

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

4.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

5.  Relation of colonial morphologies in soft agar to morphological and biological properties of the K-9 strain of Klebsiella pneumoniae and its variants.

Authors:  M Takahashi; K Yoshida; C L San Clemente
Journal:  Can J Microbiol       Date:  1977-04       Impact factor: 2.419

6.  A complementation analysis of the restriction and modification of DNA in Escherichia coli.

Authors:  H W Boyer; D Roulland-Dussoix
Journal:  J Mol Biol       Date:  1969-05-14       Impact factor: 5.469

7.  In vitro insertional mutagenesis with a selectable DNA fragment.

Authors:  P Prentki; H M Krisch
Journal:  Gene       Date:  1984-09       Impact factor: 3.688

8.  Rapid procedure for detection and isolation of large and small plasmids.

Authors:  C I Kado; S T Liu
Journal:  J Bacteriol       Date:  1981-03       Impact factor: 3.490

9.  Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans.

Authors:  D H Figurski; D R Helinski
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

10.  Direct evidence for the involvement of capsular polysaccharide in the immunoprotective activity of Klebsiella pneumoniae ribosomal preparations.

Authors:  M M Riottot; J M Fournier; H Jouin
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

View more
  104 in total

1.  Klebsiella pneumoniae outer membrane protein A is required to prevent the activation of airway epithelial cells.

Authors:  Catalina March; David Moranta; Verónica Regueiro; Enrique Llobet; Anna Tomás; Junkal Garmendia; José A Bengoechea
Journal:  J Biol Chem       Date:  2011-01-28       Impact factor: 5.157

2.  Rapid plasmid DNA isolation from mucoid gram-negative bacteria.

Authors:  P Domenico; J L Marx; P E Schoch; B A Cunha
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

3.  Virulence factors and TEM-type β-lactamases produced by two isolates of an epidemic Klebsiella pneumoniae strain.

Authors:  Frédéric Robin; Claire Hennequin; Marek Gniadkowski; Racha Beyrouthy; Joanna Empel; Lucie Gibold; Richard Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

4.  Recurring Klebsiella pneumoniae pyogenic liver abscesses in a resident of San Diego, California, due to a K1 strain carrying the virulence plasmid.

Authors:  Joshua Fierer; Lorraine Walls; Pauline Chu
Journal:  J Clin Microbiol       Date:  2011-10-12       Impact factor: 5.948

5.  Outbreak of nosocomial infections due to Klebsiella pneumoniae producing SHV-4 beta-lactamase.

Authors:  G Arlet; M J Sanson-le Pors; M Rouveau; G Fournier; O Marie; B Schlemmer; A Philippon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-11       Impact factor: 3.267

6.  Seroepidemiology of Klebsiella pneumoniae in an Australian Tertiary Hospital and its implications for vaccine development.

Authors:  Adam W Jenney; Abigail Clements; Jacinta L Farn; Odilia L Wijburg; Andrew McGlinchey; Denis W Spelman; Tyrone L Pitt; Mary E Kaufmann; Lisa Liolios; Margaret B Moloney; Steven L Wesselingh; Richard A Strugnell
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

7.  Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides.

Authors:  Miguel A Campos; Miguel A Vargas; Verónica Regueiro; Catalina M Llompart; Sebastián Albertí; José A Bengoechea
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

8.  A gene, uge, is essential for Klebsiella pneumoniae virulence.

Authors:  Miguel Regué; Beatriz Hita; Nuria Piqué; Luis Izquierdo; Susana Merino; Sandra Fresno; Vicente Javier Benedí; Juan M Tomás
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 9.  The intersection of capsule gene expression, hypermucoviscosity and hypervirulence in Klebsiella pneumoniae.

Authors:  Kimberly A Walker; Virginia L Miller
Journal:  Curr Opin Microbiol       Date:  2020-02-12       Impact factor: 7.934

10.  Klebsiella pneumoniae capsule polysaccharide impedes the expression of beta-defensins by airway epithelial cells.

Authors:  David Moranta; Verónica Regueiro; Catalina March; Enrique Llobet; Javier Margareto; Eider Larrarte; Eider Larrate; Junkal Garmendia; José A Bengoechea
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.